Multiple system atrophy of the cerebellar type (MSA-C) with concomitant beta-amyloid and tau pathology

Clinical Neuropathology

Volumn 32, Issue 4, 2013, Pages 286-290

  Bujan, Bartosz ^a   Hofer, Markus J ^a   Oertel, Wolfgang H ^a   Pagenstecher, Axel ^a   Bürk, Katrin ^a  

^a PHILIPPS UNIVERSITY MARBURG   (Germany)

Author keywords

Amyloid; Glial cytoplasmic inclusions; Lantos inclusions; Multiple system atrophy; Papp; Tau

Indexed keywords

ALPHA SYNUCLEIN; AMYLOID BETA PROTEIN; TAU PROTEIN;

AGED; ARTICLE; BRAIN DEGENERATION; CASE REPORT; CEREBELLUM; CLINICAL FEATURE; COGNITIVE DEFECT; HIPPOCAMPUS; HUMAN; HUMAN TISSUE; MALE; MESENCEPHALON; MULTIPLE SYSTEM ATROPHY OF THE CEREBELLAR TYPE; PRIORITY JOURNAL; PUTAMEN; SHY DRAGER SYNDROME; TAUOPATHY;

AGED; ALPHA-SYNUCLEIN; AMYLOID BETA-PEPTIDES; HUMANS; MALE; MULTIPLE SYSTEM ATROPHY; TAU PROTEINS;

EID: 84881497709     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: 10.5414/NP300572     Document Type: Article

References (14)

1. Gilman S, Low PA, Quinn N, Albanese A, Ben-Shlomo Y, Fowler CJ, Kaufmann H, Klockgether T, Lang AE, Lantos PL, Litvan I, Mathias CJ, Oliver E, Robertson D, Schatz I, Wenning GK. Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci. 1999; 163: 94-98.
2. Gilman S, Wenning GK, Low PA, Brooks DJ, Mathias CJ, Trojanowski JQ, Wood NW, Colosimo C, Dürr A, Fowler CJ, Kaufmann H, Klockgether T, Lees A, Poewe W, Quinn N, Revesz T, Robertson D, Sandroni P, Seppi K, Vidailhet M. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008; 71: 670-676.
3. Wenning GK, Colosimo C. Diagnostic criteria for multiple system atrophy and progressive supranuclear palsy. Rev Neurol (Paris). 2010; 166: 829-833.
4. Bürk K, Daum I, Rüb U. Cognitive function in multiple system atrophy of the cerebellar type. Mov Disord. 2006; 21: 772-776.
5. Montine TJ, Phelps CH, Beach TG, Bigio EH, Cairns NJ, Dickson DW, Duyckaerts C, Frosch MP, Masliah E, Mirra SS, Nelson PT, Schneider JA, Thal DR, Trojanowski JQ, Vinters HV, Hyman BTNational Institute on Aging; Alzheimer's Association. National Institute on Aging-Alzheimer's Association guidelines for the neuropathologic assessment of Alzheimer's disease: a practical approach. Acta Neuropathol. 2012; 123: 1-11.
6. Trojanowski JQ, Revesz T. Proposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy. Neuropathol Appl Neurobiol. 2007; 33: 615-620.
7. Angot E, Steiner JA, Hansen C, Li JY, Brundin P. Are synucleinopathies prion-like disorders? Lancet Neurol. 2010; 9: 1128-1138.
8. Franke M. Statistical investigation of the senile palques in human brains. Berlin: Akad. für Ärztl. Fortbildung der DDR, Diss. B, 1976.
9. Masliah E, Rockenstein E, Veinbergs I, Sagara Y, Mallory M, Hashimoto M, Mucke L. Beta-amyloid peptides enhance alpha-synuclein accumulation and neuronal deficits in a transgenic mouse model linking Alzheimer's disease and Parkinson's disease. Proc Natl Acad Sci USA. 2001; 98: 12245-12250.
10. Caballol N, Martí MJ, Tolosa E. Cognitive dysfunction and dementia in Parkinson disease. Mov Disord. 2007; 22 (Suppl 17): S358-S366.
11. Chang CC, Chang YY, Chang WN, Lee YC, Wang YL, Lui CC, Huang CW, Liu WL. Cognitive deficits in multiple system atrophy correlate with frontal atrophy and disease duration. Eur J Neurol. 2009; 16: 1144-1150.
12. Balas M, Balash Y, Giladi N, Gurevich T. Cognition in multiple system atrophy: neuropsychological profile and interaction with mood. J Neural Transm. 2010; 117: 369-375.
13. Kawai Y, Suenaga M, Takeda A, Ito M, Watanabe H, Tanaka F, Kato K, Fukatsu H, Naganawa S, Kato T, Ito K, Sobue G. Cognitive impairments in multiple system atrophy: MSA-C vs MSA-P. Neurology. 2008; 70: 1390-1396.
14. Brown RG, Lacomblez L, Landwehrmeyer BG, Bak T, Uttner I, Dubois B, Agid Y, Ludolph A, Bensimon G, Payan C, Leigh NP; NNIPPS Study Group. Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy. Brain. 2010; 133: 2382-2393.